- Home
- NXE
as 12-18-2024 9:40am EST
Stocks
NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.3B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 6.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.95 - $8.96 | Next Earning Date: | 11-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nexgen Energy Ltd. News
NXE Breaking Stock News: Dive into NXE Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
NextGen’s (NXE) Capital Allocation Strategy Irks Investors
Zacks
5 days ago
Wall Street Analysts See a 27.98% Upside in NexGen Energy (NXE): Can the Stock Really Move This High?
MT Newswires
7 days ago
NexGen and Denison Share Ratings, Price Targets, Maintained at National Bank of Canada
Simply Wall St.
9 days ago
With 51% ownership, NexGen Energy Ltd. (TSE:NXE) boasts of strong institutional backing
Zacks
13 days ago
Is NexGen Energy (NXE) Outperforming Other Basic Materials Stocks This Year?
Mining Technology
13 days ago
NexGen secures first uranium sales agreements with US nuclear utilities
MT Newswires
14 days ago
NexGen Energy Wins Uranium Sales Agreements
MT Newswires
14 days ago
NexGen Seals First Uranium Sales Contracts for 5 Million Pounds With Major US Utilities
Compare NXE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NXE Nexgen Energy Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.